SciGene Signs Reagent Supply Agreement with Life Technologies
SciGene announced that it has entered into an agreement whereby Invitrogen, a division of Life Technologies, will supply SciGene reagents used in its BioPrime® Total Genomic Labeling System. SciGene will incorporate the reagents into a kit for use on the ArrayPrep™ Target Preparation System, a new instrument developed by SciGene that automates labeling, purification and loading of DNA samples onto microarrays for performing aCGH tests.
Terms of the agreement were not disclosed.
Other news from the department business & finance
These products might interest you

Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation

DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference

Greener Alternative Products by Merck
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint

CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy

Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
DNA "tricked" to act as nano-building blocks - McGill researchers find new ways to manufacture nanotubes of controlled geometry, stiffness and porosities
New method helps researchers decode genomes
Denosumab Demonstrated Superiority Over Zometa in Delay of Complications Due to Bone Metastases in Advanced Prostate Cancer
Merck, Employee Representatives Agree on Efficiency Plan for Germany - Company will reduce headcount in Germany by 1,100 positions - socially acceptable implementation has already started
Boom in smart pills will reach a new peak by 2018-2020
